Clinical Trial Update: Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Tissue-of-origin Directing Therapy in Cancer of Unknown Primary Site has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary Site

Snippet

Sponsor: Fudan University | Conditions: Cancer of Unknown Primary Site | Phase 3 | Status: COMPLETED